Current NDC auxiliary source row outsourcing:2021-1:1663

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: outsourcing_history
Product Ndc Raw: 73702-128
Product Ndc: 73702-128
Product Ndc Digits: 73702128
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: [empty]
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ropivacaine Hydrochloride
Dosage Form Name: "injection, solution"
Route Name: [empty]
Marketing Category Name: OUTSOURCING FACILITY PRODUCT REPORT
Labeler Name: Wells Pharma of Houston(055774114)
Establishment Name: Wells Pharma of Houston
Establishment Fei: 055774114
Substance Name: Ropivacaine Hydrochloride
Active Ingredients Info: 2 mg/1 mL
History Active Ingredients Raw: Ropivacaine Hydrochloride
History Active Ingredients Info Raw: 2 mg/1 mL
History Dosage Raw: "injection, solution"
Dea Schedule: [empty]
Package Ndc Raw: 73702-128-95
Package Ndc: 73702-128-95
Package Ndc Digits: 7370212895
Package Ndc11: 73702012895
Package Description: 550 Ml in 1 Kit (73702-128-95)
Reporting Period Raw: 2021-1
Reporting Period: 2021-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/scripts/cder/outsourcingfacility/dsp_searchresult.cfm
Source Archive: outsourcing_2021-1.html
Source File: outsourcing_2021-1.html
Source Date: 2026-10-22
Source Last Modified: [null]
Source Archive Sha256: 62e2313425dafc3c776e5d6866dfe12853fdf3b2065b12d72f4792398810aa23
Source Member Sha256: 62e2313425dafc3c776e5d6866dfe12853fdf3b2065b12d72f4792398810aa23
Source Record Id: outsourcing:2021-1:1663
Source Row Number: 1663
Source Row Hash: 604d50b45bc315b8935c055ba8fe8c7414ae9756b0841c6219cd50a625001646
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38

Exact raw FDA source fields#

{
    "Dosage": "\"injection, solution\"",
    "Estab. Name": "Wells Pharma of Houston(055774114)",
    "Report Year": "2021-1",
    "NDC Package Code": "73702-128-95",
    "Active Ingredients": "Ropivacaine Hydrochloride",
    "Package Description": "550 Ml in 1 Kit (73702-128-95)",
    "Active Ingredients Info": "2 mg/1 mL"
}

Normalization notes#

[]

Parsed response revision#

Parsed source response revision for 2021-1

Current status projection#

Dataset: compounder
Record Source: outsourcing_history
Source Record Id: outsourcing:2021-1:1663
Source Row Number: 1663
Status Scope: package
Lookup Ndc: 73702-128-95
Lookup Ndc Digits: 7370212895
Product Ndc: 73702-128
Product Ndc Digits: 73702128
Package Ndc: 73702-128-95
Package Ndc Digits: 7370212895
Package Ndc11: 73702012895
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2021-1
Reporting Period: 2021-1
Source Table: fda_ndc_aux_compounder
Source File: outsourcing_2021-1.html
Source Date: 2026-10-22
Source Row Hash: 604d50b45bc315b8935c055ba8fe8c7414ae9756b0841c6219cd50a625001646
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38